Heterotandem bicyclic peptide complexes
US11332500B2 · kind B2 · utility
13Cited by
2References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 5, 2020 |
| Grant date | May 17, 2022 |
| Priority date | — |
| Expiry date | Oct 5, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to heterotandem bicyclic peptide complexes which comprise a first peptide ligand, which binds to a component present on a cancer cell, conjugated via a linker to a second peptide ligand, which binds to a component present on an immune cell. The invention also relates to the use of said heterotandem bicyclic peptide complexes in preventing, suppressing or treating cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.